Legend Biotech Corporation (FRA:9LB)

Germany · Delayed Price · Currency is EUR

14.70

-0.40 (-2.65%)

At close: Mar 27, 2026

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2020	FY 2018	FY 2017
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Jan '20 Jan 1, 2020	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Biotechnology	1.03B	627.30M	285.10M	117.01M	68.83M
Biotechnology Growth	64.02%	120.03%	143.66%	70.00%	-8.23%
Total	1.03B	627.30M	285.10M	117.01M	68.83M
Total Growth	64.02%	120.03%	143.66%	70.00%	-8.23%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2020	FY 2018	FY 2017
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Jan '20 Jan 1, 2020	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
United States of America	803.60M	579.10M	269.80M	116.60M	65.40M
United States of America Growth	38.77%	114.64%	131.39%	78.29%	-12.80%
China	26.60M	300.00K	200.00K	328.00K	3.42M
China Growth	8766.67%	50.00%	-39.02%	-90.42%	-
outside The United States of America	198.70M	47.90M	15.10M	-	-
outside The United States of America Growth	314.82%	217.22%	-	-	-
Europe	-	-	-	75.00K	-
Total	1.03B	627.30M	285.10M	117.01M	68.83M
Total Growth	64.02%	120.03%	143.66%	70.00%	-8.23%

Source: S&P Global Market Intelligence.